InvestLog
RNAC Cartesian Therapeutics, Inc. logo

RNAC Cartesian Therapeutics, Inc.

Healthcare
$6.45-4.44%ClosedMarket Cap: $189.5M

As of 2026-05-26

Insider Statistics (Q1 2026)

Acquisitions

24

Dispositions

4

Buy/Sell Ratio

6.00

Net Shares

+957,715

Shares Acquired

1,002,200

Shares Disposed

44,485

Total Bought ($)

$0.00

Total Sold ($)

$3.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon Apr 06Kalayoglu Murat10 percent ownerSell758,001$0.005,313,261
Mon Apr 06Kalayoglu Murat10 percent ownerSell22,740$0.0033,662
Mon Apr 06Hoge Elizabeth10 percent ownerSell758,001$0.005,313,261
Mon Apr 06Hoge Elizabeth10 percent ownerSell22,740$0.0033,662
Fri Mar 13Singer MichaeldirectorSell6,555$0.0049,578
Thu Jan 08Miljkovic Milosofficer: Chief Medical OfficerSell3,573$6.8258,820
Thu Jan 08Davis Blaineofficer: Chief Financial OfficerSell10,591$6.82121,220
Thu Jan 08Brunn Carstendirector, officer: President and CEOSell23,766$6.82323,530
Tue Jan 06Malik KemaldirectorSell7,800$6.767,800
Tue Jan 06Malik KemaldirectorSell2,600$0.0011,133
Tue Jan 06DeSilva Nishan MdirectorSell7,800$6.767,800
Tue Jan 06DeSilva Nishan MdirectorSell2,600$0.0011,366
Tue Jan 06Brunn Carstendirector, officer: President and CEOSell415,700$6.76415,700
Tue Jan 06Brunn Carstendirector, officer: President and CEOSell143,200$0.00347,296